Literature DB >> 1887332

Transduction of the CHO aprt gene into mouse L cells using an adeno-5/APRT recombinant virus.

V Konan1, A Sahota, F L Graham, M W Taylor.   

Abstract

An adenovirus-5 recombinant virus Adapt1 carrying the Chinese hamster ovary (CHO) adenine phosphoribosyltransferase (aprt) gene was constructed by insertion of a 2.5-kb fragment containing the complete CHO aprt structural gene linked to a Moloney murine sarcoma virus (MSV) promoter into the E3 region of adenovirus-5. The CHO aprt gene was in the opposite orientation to the adenovirus E3 promoter. Mouse Lapt- tk- (LAT) cells expressed the CHO aprt gene when infected with the virus, even at low MOI (O.1). APRT activity was detectable from approximately 20 h postinfection. At a low frequency, LAT cells were transformed to aprt+, and four stable transductants were selected in adenine, azaserine (AA) medium. Such cells expressed APRT at approximately 50% wild-type activity and the enzyme was shown to be CHO APRT by starch gel electrophoresis. DNA was isolated from the transductants and probed with CHO aprt-specific DNA and with viral DNA probes. The results indicated that the CHO aprt gene was integrated into the LAT cells at a site other than mouse aprt. Although neighboring viral sequences were integrated and maintained in the transductants, viral sequences further upstream and downstream of the aprt gene were absent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1887332     DOI: 10.1007/bf01233061

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  2 in total

1.  Receptor-targeted recombinant adenovirus conglomerates: a novel molecular conjugate vector with improved expression characteristics.

Authors:  P Schwarzenberger; J D Hunt; E Robert; C Theodossiou; J K Kolls
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Correction of a deletion mutant by gene targeting with an adenovirus vector.

Authors:  Q Wang; M W Taylor
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.